About Canfel Therapeutics

About company

CanFel's founding team has extensive experience discovering and developing antibody drugs for use in humans and is applying this expertise to develop new antibody drugs for companion animals. Leveraging CanFel's innovative, "biology-driven" cCSC development platform, that utilizes advanced cell-based discovery techniques, they are developing canine and feline versions of antibody therapeutics widely used to treat cancer in humans.